Purchases and Sales Made in Q2 2023 in Benitec Biopharma Inc. (BNTC)
This table provides information about the institutional ownership of Benitec Biopharma Inc. (BNTC) during Q2 2023. The information is specifically focused on institutions that hold shares of Benitec Biopharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 08, 2023
Q2 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
3.16KNew |
$601 - $1.14K
|
3.16K
$33.2K
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
9+ 4.66% |
$1.71 - $3.24
|
202
$2.12K
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-96- 1.27% |
$18.2 - $34.6
|
7.47K
$78.3K
|
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-6.9K- 15.16% |
$1.31K - $2.48K
|
38.6K
$405K
|
|
|
Jul 27, 2023
Q2 2023
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-68.6K- 56.49% |
$13K - $24.7K
|
52.9K
$555K
|